查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855643

輸尿管鏡設備市場（按設備類型、應用、最終用戶、技術和配件分類）—2025-2032年全球預測

Ureteroscopy Devices Market by Device Type, Application, End User, Technology, Accessories - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，輸尿管鏡設備市場規模將成長 38 億美元，複合年成長率為 7.32%。

關鍵市場統計數據
基準年 2024 21.5億美元
預計年份：2025年 23.1億美元
預測年份 2032 38億美元
複合年成長率 (%) 7.32%

全面介紹輸尿管鏡設備的發展歷程，包括臨床需求、技術進步、採購動態、對策略性相關人員的影響。

輸尿管鏡設備處於泌尿系統手術創新和微創醫療服務的交匯點，同時滿足了臨床醫生、醫療系統和患者對更清晰的視野、更低的手術風險和更快的康復的需求。臨床上對精準治療結石和尿路上皮病變的需求，持續推動光學系統、能量傳輸系統以及輔助耗材的發展，以提升取石和腫瘤切除的流程效率。同時，醫院和門診手術中心不斷變化的優先事項正在影響採購週期和設備偏好，而監管和報銷環境則決定輸尿管鏡設備的普及速度。

數位影像處理和一次性平台的技術進步正在推動醫療保健領域資本和營運模式的重新思考。數位軟性輸尿管鏡提高了影像清晰度，並增強了與輔助成像系統的整合度；一次性產品的出現則是為了應對消毒的複雜性、交叉感染的風險以及吞吐量的限制。同時，雷射技術和配件設計（例如旨在提高操作性和碎石效率的取石籃和光纖）的進步，正在縮小臨床醫生在選擇器械時必須權衡的手術方案範圍。

在此背景下，相關人員必須權衡臨床療效、手術總成本和供應穩定性。隨著診療路徑日益碎片化，泌尿系統手術在門診進行的比例不斷增加，器械設計和操作環境的完整性將成為商業性成功的關鍵決定因素。本摘要的其餘部分將概述最重要的轉變、監管和貿易影響、市場細分影響、區域差異，並為希望有效定位其產品組合的領導者提供明確的建議。

輸尿管鏡檢查領域正在發生變革性變化，影響臨床實務、技術應用和商業策略。

輸尿管鏡器材領域正經歷多重整合的變革，這些變革正在改變臨床實踐和商業性價值。首先，高解析度數位光學技術的成熟正在改變臨床醫生對影像品質和術中決策的期望，從而能夠更精細地表徵病變並進行更明確的治療操作。與手術室視覺化和影像管理系統的日益融合進一步強化了這一轉變，提升了輸尿管鏡在複雜診斷和治療流程中的作用。

其次，一次性技術的興起正在重塑採購模式和感染控制策略。醫療機構在評估一次性使用方案時，不僅考慮每次操作的成本，還考慮其效率、再處理工作量以及降低交叉感染風險等因素。這正在形成一種混合採用模式，可重複使用和一次性器械並存，採購決策主要受手術量、消毒能力和臨床偏好驅動。

第三，能量傳輸和配件方面的創新，特別是雷射光纖性能和取石籃設計的進步，正在改變內視鏡手術的限制。碎石效率和腫瘤切除精度的提高，減少了分期手術的需求，並擴大了微創治療的適用人群。這些臨床效益正在轉化為住院和門診手術比例的轉變。

最後，分散式醫療服務和門診手術中心的興起正促使製造商最佳化產品系列，以提高便攜性、簡化安裝和快速週轉率。總而言之，這些轉變既為產品開發商及其醫療系統合作夥伴帶來了機會，也帶來了挑戰，需要協調投資於臨床培訓、實證醫學和供應鏈靈活性，才能實現潛在效益。

2025年美國關稅對供應鏈結構、採購決策與成本透明度的累積影響

近期公佈的關稅措施和2025年貿易政策訊號凸顯了輸尿管鏡設備產業企業供應鏈配置的重要性。針對特定醫療設備原料和成品的關稅調整迫使製造商和經銷商重新評估其採購佈局、近岸外包方案和庫存策略，以維持成本競爭力和交付可靠性。為此，各企業正日益關注二級和三級供應商的依賴關係，以識別潛在的關稅風險，並制定涵蓋合約重新談判、替代採購和選擇性垂直整合等應對方案。

這些政策轉變也影響定價透明度以及與醫療系統和集團採購組織的合約談判能力。醫療服務提供者要求更清楚地了解岸成本和緊急條款，採購週期中也擴大納入應對進口關稅和供應中斷的條款。這些因素累積作用，使得企業更加重視情境規劃，並在不同的貿易政策路徑下對商業模式進行壓力測試。

在製造業方面，一些公司正在加快本地組裝或認證非關稅區的替代契約製造，以降低關稅負擔並縮短前置作業時間。另一些公司則在重新設計零件規格，以盡量減少使用關稅複雜的物項，還有一些公司則在利用現有的關稅減免機制。值得注意的是，這些因應措施並不均衡。中小企業與規模較大的成熟企業相比，面臨不同的限制因素，這會影響它們的競爭動態和潛在的整合活動。

展望未來，關稅政策與全球醫療設備貿易之間的相互作用將繼續影響投資選擇、戰略夥伴關係以及可重複使用和一次性器械模式的相對吸引力。

主導細分市場的洞察，將設備類型、臨床應用、終端用戶環境、技術路徑和配件生態系統轉化為策略重點。

有效的商業策略始於對細分市場的精準理解。以器械類型為例，軟性輸尿管鏡和半硬性系統之間存在差異。在軟性輸尿管鏡領域，可進一步區分注重高解析度成像的數位軟性平台和專注於傳統光纖傳輸架構的光纖軟性平台。這些器械層面的選擇會影響手術範圍、維修和再處理成本以及資金預算分配，因此每種器械都需要不同的臨床依據和培訓方法來推動其應用。

應用層級的細分區分了診斷和治療兩種應用情境。診斷應用著重於病灶檢測和定位所需的檢查和視覺化功能，而治療應用則分為結石管理和腫瘤管理。結石管理流程進一步細分為取石籃策略和以體外震波碎石為中心的方案，每種方案都有其獨特的配件相容性和操作人體工學要求。腫瘤管理流程依賴精確的切片檢查能力和雷射消熔性能，這會影響設備的光學、偏轉和能量傳輸要求。

最終用戶環境對設備採用模式起著至關重要的作用。無論是獨立營運還是隸屬於醫院的門診手術中心，都優先考慮手術效率、簡化的再處理流程以及可預測的單例手術營運成本；而無論是私立醫院還是公立醫院，在選擇設備時則更注重資本攤銷、手術種類豐富度以及服務水平預期。這些差異導致了不同醫療機構在商業性訊息、報銷承諾和採用模式上的差異。

技術細分揭示了數位輸尿管鏡和光纖輸尿管鏡的平行發展。可重複使用型和拋棄式輸尿管鏡之間的策略選擇取決於消毒基礎設施、手術量和長期擁有成本的計算。最後，配件細分——例如雷射光纖與取石籃、钬光纖與铥光纖、標準取石籃與無尖端取石籃——決定了捆綁銷售的機會和售後市場收入潛力。將產品藍圖與這些細分領域相匹配，有助於產生更有針對性的證據、制定量身提案的價值主張並實現差異化的商業性執行。

區域洞察分析著重闡述美洲、歐洲、中東和非洲以及亞太地區的市場採納動態和結構性差異，並為打入市場策略提供啟示。

地理位置對醫療器材的普及和商業性化進程有顯著影響。在美洲，大型綜合醫療系統、實力雄厚的私立醫院以及活躍的門診手術中心網路，共同推動了對高通量一次性拋棄式和功能豐富的可重複使用平台的需求。該地區的醫保報銷結構和資本規劃週期，通常更傾向於已證實具有臨床效率提升且單次手術成本可預測的醫療器械，從而影響著產品在醫院和門診環境中的價值評估。此外，該地區的診療路徑最佳化計畫和醫院整合趨勢也會影響採購量和標準化機會。

歐洲、中東和非洲地區不同的報銷模式、監管時間表和醫療基礎設施導致了不同的醫療設備應用模式。資源豐富的市場優先考慮先進的影像處理和用於預防感染的一次性設備，而新興的醫療體系則優先考慮耐用、可維修且有本地服務網路支援的設備。這些市場的採購也會受到特定國家/地區的合約結構和當地經銷商的影響，因此需要客製化的價格和服務提案。

亞太地區正經歷著都市區三級醫療中心快速普及微創泌尿外科技術以及區域醫院和門診機構服務範圍不斷擴大的雙重趨勢。該地區對微創泌尿系統的投資以及不斷提升的手術能力，為兼顧資本投入和單例經濟效益的擴充性器械解決方案提供了支持。與本地製造商和經銷商建立合作關係，以及開展旨在規範手術流程的培訓項目，對於加速微創泌尿外科技術在亞太地區多樣化醫療環境中的應用尤為有效。

了解這些區域差異，可以讓製造商優先考慮證據產生、監管策略、當地採購行為、報銷優先事項以及符合商業現實的商業模式。

公司層面的洞察重點在於產品組合差異化、製造地、智慧財產權趨勢和夥伴關係模式。

輸尿管鏡設備領域的競爭格局取決於各公司如何建構產品系列，包括可重複使用和一次性光學元件、能量傳輸系統以及配套配件。領先的創新企業優先考慮整合解決方案，將高解析度視覺化、最佳化的雷射相容性和客製化的附件生態系統相結合，以創建連貫的臨床工作流程。中型企業則通常強調針對特定目標的價值提案，例如經濟實惠的一次性產品以及專用取物籃和光纖，以搶佔特定手術領域的市場佔有率。

製造地和垂直整合能力會影響企業的競爭地位。擁有多元化生產和區域組裝能力的企業更能抵禦關稅波動和供應鏈中斷的影響，而依賴集中式生產的企業則面臨不同的風險。與契約製造製造商合作、建立零件採購策略聯盟以及與臨床意見領袖共同開發契約，有助於在不損害企業財務狀況的前提下拓展產品線。

智慧財產權和監管策略進一步凸顯了企業的差異化優勢。專有的影像軟體、獨特的偏轉機制和光纖技術構築了准入壁壘，並結合嚴格的臨床檢驗，協助企業實現高階定位。同時，有效利用售後市場收入（例如配件、耗材和服務合約）的企業，能夠增強經常性收入來源，並深化客戶關係。

最後，市場進入策略也多種多樣，從強調廣泛臨床培訓和醫院整合的直銷模式，到優先考慮更廣泛地域覆蓋的分銷商主導策略，不一而足。最成功的公司會根據上文討論的終端用戶細分和地理實際情況，量身定做其商業模式，投資於臨床證據、教育項目和服務網路，以滿足臨床醫生和採購團隊的實際需求。

為行業領導者提供切實可行的建議，以加速採用、增強韌性並在臨床和商業路徑中獲取價值

產業領導者應優先考慮模組化產品組合策略，以協調可重複使用設備和一次性設備並存。具體而言，產品設計應符合門診手術中心和醫院的運作實際情況，並專注於設定時間、消毒負擔和配件相容性，這將有助於產品得到更廣泛的應用。此外，開展有針對性的臨床證據項目，證明產品能夠提高手術效率並改善以患者為中心的治療效果，對於與大型醫療機構和支付者進行有效溝通至關重要。

供應鏈韌性必須提升為策略重點。企業應擴大關鍵零件的多通路採購能力，在可行的情況下對區域組裝合作夥伴進行資格認證，並對關稅敏感型投入品實施庫存緩衝。這些措施將有助於減輕貿易政策變化的影響，並確保向關鍵客戶交貨產品的可預測性。

在商業性，企業應採用差異化的合作模式，以反映終端用戶細分。對於三級醫院而言，注重實踐培訓、指導和結果追蹤的高觸感項目更為有效；而對於門診手術中心而言，簡化的採購方案和可預測的單例成本核算則更為適用。將內視鏡、最佳化的雷射光纖和相容的配件打包在一起，可以簡化採購決策，並建立可衡量的總醫療成本系統。

最後，投資數位化賦能和資料擷取，以量化流程層面的績效，並支持與醫療服務提供者進行基於價值的對話。遠端指導、遠端設備健康遠距離診斷和使用率分析報告能夠創造更多收入和服務差異化的機會，同時增強臨床信任和建立長期夥伴關係。

調查方法概述了數據三角測量、專家參與、檢驗通訊協定和分析框架，這些方法和框架用於得出本文提出的見解。

本研究採用多資訊研究途徑，將對臨床醫生、採購負責人和行業高管的專家訪談與監管文件、臨床文獻和設備技術規範等輔助研究結合。主要資訊來源包括結構化訪談，旨在了解醫院和門診環境中的手術流程、設備偏好和採購標準。輔助分析則著重於設備設計特點、配件相容性和已發表的臨床結果，以檢驗臨床實踐模式和技術性能聲明。

本分析採用以細分為先的框架，以確保能夠深入了解設備類型、臨床用途、最終用戶環境、技術配置和配件生態系統。交叉檢驗通訊協定將基於訪談的觀察結果與產品文獻和公開監管記錄進行比較，以確認有關設備功能和預期用途的說法。敏感性檢查透過對來自多個臨床和商業性相關人員的意見進行加權，來解決單一來源證詞可能造成的偏差。

我們對關稅和供應鏈應對措施的影響進行了解讀，結合了政策評估、供應商層面的資訊揭露以及採購負責人的觀點，從而建構出切實可行的潛在策略應對方案。我們的區域分析包括對代表性市場的臨床醫生進行訪談，並審查報銷和採購結構，以突出實際應用限制和促進因素。這些調查方法提供了基於證據的綜合分析，可為決策者制定商業規劃和產品策略提供支援。

總結策略意義，並為希望根據執行摘要結果採取行動的相關人員概述優先的後續步驟

輸尿管鏡設備領域正處於曲折點，其特點是光學、能量傳輸和配件設計方面的進步，以及採購和醫療服務模式的轉變。這些因素為那些能夠將產品功能與醫院和門診手術中心的營運需求相結合，同時又能應對供應鏈韌性和不斷變化的貿易政策風險的公司創造了明顯的機會。最終能否被廣泛接受，取決於能否證明其臨床價值、簡化手術流程，以及在各種醫療環境中實現可預測的營運經濟效益。

相關人員的下一步優先步驟包括：明確細分市場的價值提案；加快針對性臨床證據的收集，以滿足終端用戶的需求；以及增強生產和採購的靈活性，以應對關稅和物流中斷的影響。此外，各機構還需要最佳化其商業策略，以反映區域報銷的實際情況，並針對不同類型的購買者（包括私人醫院、商業性醫院、獨立門診機構和醫院附屬門診中心）調整通訊。

透過關注這些策略問題，企業及其醫療服務提供者合作夥伴可以成功應對不斷變化的市場環境，抓住技術創新帶來的機遇，並改善接受診斷性和治療性輸尿管鏡檢查患者的治療效果。報告的其餘部分提供了詳細的附錄以及實用化這些結論所需的依證。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 增加一次性輸尿管鏡的使用，以降低污染風險
  • 將高清數位成像系統整合到軟性輸尿管鏡平台中
  • 開發用於提高手術精度的機器人輸尿管鏡平台
  • 雷射碎石術相容性的進步可加快輸尿管結石的碎裂速度
  • 小型化可彎曲內視鏡的出現，最大限度地降低了輸尿管損傷的風險。
  • 人工智慧在即時石材檢測和測繪領域的應用日益廣泛
  • 符合人體工學的手把設計日益普及，旨在減少外科醫生在長時間輸尿管鏡檢查過程中的疲勞。
  • 重點關注永續材料和回收舉措，以實現環保輸尿管鏡製造。
  • 擴大一次性數位軟性內視鏡的使用範圍，以縮短消毒週轉時間
  • 泌尿系統設備製造商與人工智慧Start-Ups活性化，共同創新內視鏡技術

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依設備類型分類的輸尿管鏡設備市場

  • 軟性輸尿管鏡
    • 數位軟性
    • 光纖軟性
  • 半硬式輸尿管鏡

9. 按應用分類的輸尿管鏡設備市場

  • 診斷
    • 檢查
    • 視覺化
  • 治療
    • 石材管理
      • 籃框提取
      • 碎石
    • 腫瘤管理
      • 切片檢查
      • 雷射消熔

第10章 以最終用戶分類的輸尿管鏡設備市場

  • 門診手術中心
    • 獨立的
    • 附設醫院
  • 醫院
    • 私立醫院
    • 公立醫院

第11章 依技術分類的輸尿管鏡設備市場

  • 數位輸尿管鏡
    • 可重複使用的
    • 一次使用
  • 纖維輸尿管鏡
    • 可重複使用的
    • 一次使用

第12章 輸尿管鏡設備市場（依配件分類）

  • 雷射光纖
    • 鈥雷射光纖
    • 铥雷射光纖
  • 石籃
    • 標準籃筐
    • 無傾倒籃

第13章 輸尿管鏡設備市場（按地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 輸尿管鏡設備市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國輸尿管鏡設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Olympus Corporation
    • KARL STORZ SE & Co. KG
    • Boston Scientific Corporation
    • Cook Medical LLC
    • Stryker Corporation
    • Richard Wolf GmbH
    • Ambu A/S
    • Fujifilm Holdings Corporation
    • Teleflex Incorporated
    • Coloplast A/S
Product Code: MRR-4659C87137F4

The Ureteroscopy Devices Market is projected to grow by USD 3.80 billion at a CAGR of 7.32% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.15 billion
Estimated Year [2025] USD 2.31 billion
Forecast Year [2032] USD 3.80 billion
CAGR (%) 7.32%

A comprehensive introduction framing ureteroscopy device evolution across clinical demand, technology progress, procurement dynamics, and implications for strategic stakeholders

Ureteroscopy devices sit at the intersection of urology procedural innovation and minimally invasive care delivery, responding to simultaneous pressures from clinicians, healthcare systems, and patients for improved visualization, reduced procedural risk, and faster recovery. The clinical imperative to manage stone disease and urothelial lesions with precision has driven sustained interest in optics, energy delivery, and ancillary disposables that enhance stone extraction and tumor ablation workflows. Concurrently, evolving hospital and ambulatory surgical center priorities influence procurement cycles and device preference, while regulatory and reimbursement environments shape the speed of adoption.

Technological advances in digital imaging and single-use platforms have catalyzed reconsideration of capital and operating models across care settings. Digital flexible ureteroscopes have elevated image clarity and integration with ancillary imaging systems, while single-use offerings have emerged in response to sterilization complexity, cross-contamination concerns, and throughput constraints. At the same time, developments in laser technology and accessory design-such as baskets and fibers engineered for improved maneuverability and fragmentation efficiency-have narrowed the procedural trade-offs that clinicians weigh during device selection.

In this context, stakeholders must balance clinical efficacy, total procedural cost, and supply resilience. As care pathways decentralize and outpatient settings take on a larger share of urologic procedures, alignment between device design and operating environment becomes a critical determinant of commercial success. The remainder of this summary synthesizes the most consequential shifts, regulatory and trade impacts, segmentation-driven implications, regional nuances, and clear recommendations for leaders seeking to position their portfolios effectively.

Transformative Shifts Reshaping Clinical Practice, Technology Adoption, and Commercial Strategy in Ureteroscopy

The landscape for ureteroscopy devices is undergoing several convergent transformations that are altering clinical practice and commercial calculus. First, the maturation of high-resolution digital optics has changed clinician expectations for image quality and intraoperative decision making, enabling finer lesion characterization and more confident therapeutic maneuvers. This shift is reinforced by better integration with operating room visualization suites and image management systems, which together advance the role of ureteroscopy in complex diagnostic and therapeutic pathways.

Second, the rise of single-use technology is reshaping procurement models and infection control strategies. Facilities increasingly evaluate single-use options not solely on per-procedure cost but on throughput, reprocessing labor, and cross-infection risk mitigation. This has led to hybrid adoption patterns in which reusable and single-use systems coexist, with purchasing decisions driven by procedure volume, sterilization capacity, and clinical preference.

Third, energy delivery and accessory innovation, especially in laser fiber performance and basket design, are shifting the boundary of what can be achieved endoscopically. Improvements in lithotripsy efficiency and tumor ablation precision reduce the need for staged procedures and broaden the patient population eligible for minimally invasive management. These clinical gains translate into shifting procedural mixes across inpatient and ambulatory venues.

Finally, decentralized care delivery and growth in ambulatory surgical centers are prompting manufacturers to refine product portfolios for portability, simplified setup, and rapid turnover. Taken together, these shifts create both opportunity and complexity for product developers and health system partners, demanding coordinated investments in clinical training, evidence generation, and supply chain agility to realize potential gains.

Cumulative Impacts of United States Tariff Actions in 2025 on Supply Chain Structuring, Sourcing Decisions, and Cost Transparency

Recent tariff actions and trade policy signals announced for 2025 have increased the salience of supply chain configuration for companies operating in the ureteroscopy device space. Tariff adjustments applied to certain medical device inputs and finished goods have prompted manufacturers and distributors to reassess sourcing footprints, nearshoring options, and inventory strategies to preserve cost competitiveness and delivery reliability. In response, organizations are increasingly mapping supplier dependencies at the tier-two and tier-three levels to identify latent exposure to tariffed goods and to develop mitigation plans that span contract renegotiation, alternative sourcing, and selective vertical integration.

These policy shifts also influence pricing transparency and contractual negotiation dynamics with health systems and group purchasing organizations. Providers are demanding greater visibility into landed costs and contingency provisions, and procurement cycles now frequently incorporate clauses addressing import duties and supply interruptions. The cumulative effect has been a heightened emphasis on scenario planning and stress-testing commercial models under different trade policy trajectories.

On the manufacturing side, some firms are accelerating localized assembly or qualifying alternate contract manufacturers in non-tariff jurisdictions to reduce duty burden and shorten lead times. Others are redesigning component specifications to minimize the use of tariff-implicated items, while a subset is leveraging tariff mitigation mechanisms where available. Importantly, these responses are not uniform; small and mid-sized companies face different constraints compared with large established firms, which affects competitive dynamics and potential consolidation activity.

Going forward, the interplay between tariff policy and global medical device trade will continue to shape investment choices, strategic partnerships, and the relative attractiveness of reusable versus disposable device models, as duty-sensitive cost components flow through to procurement decisions and clinical adoption patterns.

Segmentation-driven insights translating device type, clinical application, end-user environment, technology pathways, and accessory ecosystems into strategic priorities

An effective commercial strategy begins with precise segment-level understanding. Device type considerations differentiate flexible ureteroscopes from semi-rigid systems; within flexible offerings, a further distinction exists between digital flexible platforms that prioritize high-definition visualization and fiber-optic flexible variants that emphasize traditional light-transmitting architectures. These device-level choices affect procedure scope, repair and reprocessing burdens, and capital budget allotments, and they require distinct clinical evidence and training approaches to drive adoption.

Application-level segmentation separates diagnostic use from therapeutic deployment. Diagnostic applications emphasize inspection and visualization capabilities necessary for lesion detection and mapping, while therapeutic use cases split between stone management and tumor management. Stone management workflows further bifurcate into basket extraction strategies and lithotripsy-centric approaches, each demanding specific accessory compatibility and procedural ergonomics. Tumor management workflows rely on precise biopsy capability and laser ablation performance, which in turn influence device optics, deflection, and energy delivery requirements.

End-user context plays a critical role in adoption patterns. Ambulatory surgical centers, whether freestanding or hospital-affiliated, prioritize throughput efficiency, simplified reprocessing, and predictable per-case operating expenses, whereas hospitals, whether private or public, weigh capital depreciation, breadth of procedural mix, and service-level expectations when selecting devices. These differences drive varied commercial messaging, reimbursement engagement, and deployment models across providers.

Technology segmentation highlights the parallel development of digital and fiber-optic ureteroscopes, each available in reusable and single-use configurations. Strategic choices between reusable and single-use variants hinge on sterilization infrastructure, procedural volume, and long-term cost-of-ownership calculus. Finally, accessory segmentation-such as distinctions between laser fibers and stone baskets and between holmium and thulium fibers or standard and tipless baskets-shapes bundled offering opportunities and aftermarket revenue potential. Aligning product roadmaps to these layered segments enables focused evidence generation, tailored value propositions, and differentiated commercial execution.

Regional insights highlighting adoption dynamics and structural differences across the Americas, Europe Middle East & Africa, and Asia-Pacific with implications for go-to-market strategies

Geographic context materially influences device adoption and commercial execution. In the Americas, large integrated health systems, a strong private hospital presence, and active ambulatory surgical center networks create demand for both high-throughput disposables and feature-rich reusable platforms. Reimbursement structures and capital planning cycles in this region often favor demonstrable clinical efficiency gains and predictable per-procedure costing, which shapes how products are evaluated across hospital and ambulatory settings. Additionally, pathway optimization initiatives and hospital consolidation trends in this region affect purchasing scale and standardization opportunities.

Within Europe, the Middle East & Africa, diversity in reimbursement models, regulatory timelines, and health infrastructure results in differentiated uptake patterns. High-resource markets place a premium on advanced imaging and single-use infection control benefits, while emerging healthcare systems emphasize durable, repairable devices supported by local service networks. Procurement in these markets may also be influenced by national contracting vehicles and regional distributors, necessitating tailored pricing and service propositions.

Asia-Pacific presents a mix of rapid adoption in urban tertiary centers and widening access in regional hospitals and ambulatory facilities. Investments in minimally invasive urology and expanding surgical capacity within the region favor scalable device solutions that balance capital expenditure with per-case economics. Partnerships with local manufacturers and distributors, along with training programs oriented toward procedure standardization, are particularly effective in accelerating adoption across diverse healthcare settings in Asia-Pacific.

Understanding these regional nuances allows manufacturers to prioritize evidence generation, regulatory strategy, and commercial models that align with local procurement behavior, reimbursement priorities, and operational realities.

Company-level insights focusing on portfolio differentiation, manufacturing footprint, intellectual property trends, and partnership models

Competitive dynamics in the ureteroscopy devices space are shaped by how firms configure product portfolios across reusable and disposable optics, energy delivery systems, and complementary accessories. Leading innovators prioritize integrated solutions that combine high-resolution visualization with optimized laser compatibility and bespoke accessory ecosystems to create sticky clinical workflows. Mid-market players frequently emphasize targeted value propositions-such as cost-effective single-use offerings or specialized baskets and fibers-to capture specific procedural niches.

Manufacturing footprint and vertical capability influence competitive positioning. Firms with diversified production and regional assembly capabilities can respond more flexibly to tariff shifts and supply disruptions, while those relying on concentrated manufacturing face different risk profiles. Partnerships with contract manufacturers, strategic alliances for component sourcing, and co-development agreements with clinical opinion leaders help expand product breadth without undermining balance sheets.

Intellectual property and regulatory strategy further differentiate companies. Proprietary imaging software, unique deflection mechanisms, and fiber technologies create barriers to entry and enable premium positioning when accompanied by rigorous clinical validation. At the same time, firms that effectively leverage aftermarket revenue through accessories, consumables, and service agreements strengthen recurring revenue streams and deepen customer relationships.

Finally, go-to-market approaches vary from direct sales models focused on high-touch clinical training and hospital integration to distributor-led strategies that prioritize broader geographic reach. The most successful organizations align their commercial model with the end-user segmentation and regional realities described earlier, investing in clinical evidence, education programs, and service networks that address the practical needs of clinicians and procurement teams.

Actionable recommendations for industry leaders to accelerate adoption, strengthen resilience, and capture value across clinical and commercial pathways

Industry leaders should prioritize modular portfolio strategies that reconcile the coexistence of reusable and single-use modalities. Specifically, aligning product design with the operational realities of ambulatory surgical centers and hospitals-focusing on setup time, sterilization burden, and accessory compatibility-will support wider adoption. In tandem, targeted clinical evidence programs that demonstrate procedural efficiency gains and patient-centered outcomes will be decisive in conversations with high-volume institutions and payers.

Supply chain resilience must be elevated to a strategic priority. Companies should expand multi-sourcing capabilities for critical components, qualify regional assembly partners where feasible, and implement inventory buffering for tariff-sensitive inputs. These actions reduce exposure to trade policy shifts and support predictable delivery performance for key customers.

Commercially, firms should adopt differentiated engagement models that reflect end-user segmentation. High-touch programs emphasizing hands-on training, proctoring, and outcomes tracking work well for tertiary hospitals, while streamlined procurement options and predictable per-case costing resonate with ambulatory surgical centers. Bundled offerings that package scopes, optimized laser fibers, and compatible baskets can simplify purchasing decisions and create measurable total cost of care narratives.

Finally, invest in digital enablement and data capture to quantify procedure-level performance and support value-based conversations with providers. Tele-mentoring, remote diagnostics for device health, and analytics reporting on utilization create additional revenue and service differentiation opportunities while reinforcing clinical trust and long-term partnerships.

Research methodology outlining data triangulation, expert engagement, validation protocols, and analytical frameworks used to derive the insights presented

This synthesis is grounded in a multi-source research approach that integrates primary expert interviews with clinicians, procurement leaders, and industry executives, combined with secondary examination of regulatory filings, clinical literature, and device technical specifications. The primary input included structured interviews designed to capture procedural workflows, device preferences, and procurement criteria across hospital and ambulatory settings. Secondary analysis focused on device design features, accessory compatibility, and published clinical outcomes to validate practice patterns and technology performance claims.

The analysis employed a segmentation-first framework to ensure that insights were relevant to device type, clinical application, end-user environment, technology configuration, and accessory ecosystems. Cross-validation protocols compared interview-based observations against product literature and public regulatory records to confirm claims regarding device capabilities and intended use cases. Sensitivity checks addressed potential bias from single-source testimony by weighting input across multiple clinical and commercial stakeholders.

Interpretation of tariff impacts and supply chain responses combined policy review with supplier-level disclosure and procurement leader perspectives to generate a practical view of likely strategic responses. The regional analysis drew on clinician interviews in representative markets and review of reimbursement and procurement structures to surface realistic adoption constraints and enablers. Together, these methodological elements produced an evidence-informed synthesis designed to support decision makers in commercial planning and product strategy.

Conclusion synthesizing strategic implications and outlining priority next steps for stakeholders seeking to act on the executive summary findings

The ureteroscopy device landscape is at an inflection point defined by converging advances in optics, energy delivery, and accessory design coupled with shifting procurement and care delivery models. These forces create distinct opportunities for firms that can align product functionality with the operational needs of hospitals and ambulatory surgical centers, while simultaneously addressing supply chain resilience and evolving trade policy risk. Adoption choices will hinge on the ability to demonstrate clinical value, simplify procedural workflows, and deliver predictable operating economics for diverse care settings.

Priority next steps for stakeholders include clarifying segment-specific value propositions, accelerating targeted clinical evidence that maps to end-user priorities, and strengthening manufacturing and sourcing flexibility to respond to tariff and logistics disruptions. Organizations should also refine commercial approaches to reflect regional reimbursement realities and to adapt messaging for distinct buyer types across private hospitals, public hospitals, freestanding ambulatory facilities, and hospital-affiliated outpatient centers.

By focusing on these strategic imperatives, companies and provider partners can better navigate the evolving landscape, capture opportunities presented by technological innovation, and deliver improved outcomes for patients undergoing diagnostic and therapeutic ureteroscopic procedures. The remainder of the report offers the detailed appendices and evidence base required to operationalize these conclusions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of single-use disposable ureteroscopes to reduce contamination risks
  • 5.2. Integration of high-definition digital imaging systems in flexible ureteroscope platforms
  • 5.3. Development of robot assisted ureteroscopy platforms for enhanced surgical precision
  • 5.4. Advancements in laser lithotripsy compatibility for faster ureteral stone fragmentation
  • 5.5. Emergence of miniaturized deflectable scopes to minimize ureteral trauma risks
  • 5.6. Rising implementation of artificial intelligence for real time stone detection and mapping
  • 5.7. Surge in ergonomic handle designs to reduce surgeon fatigue during prolonged ureteroscopy procedures
  • 5.8. Focus on sustainable materials and recycling initiatives for eco friendly ureteroscope production
  • 5.9. Expansion of single use digital flexible scopes to reduce sterilization turnaround times
  • 5.10. Rising collaborations between urology device manufacturers and AI startups for scope innovation

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ureteroscopy Devices Market, by Device Type

  • 8.1. Flexible Ureteroscopes
    • 8.1.1. Digital Flexible
    • 8.1.2. Fiber-Optic Flexible
  • 8.2. Semi-Rigid Ureteroscopes

9. Ureteroscopy Devices Market, by Application

  • 9.1. Diagnostic
    • 9.1.1. Inspection
    • 9.1.2. Visualization
  • 9.2. Therapeutic
    • 9.2.1. Stone Management
      • 9.2.1.1. Basket Extraction
      • 9.2.1.2. Lithotripsy
    • 9.2.2. Tumor Management
      • 9.2.2.1. Biopsy
      • 9.2.2.2. Laser Ablation

10. Ureteroscopy Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
    • 10.1.1. Freestanding
    • 10.1.2. Hospital Affiliated
  • 10.2. Hospitals
    • 10.2.1. Private Hospitals
    • 10.2.2. Public Hospitals

11. Ureteroscopy Devices Market, by Technology

  • 11.1. Digital Ureteroscopes
    • 11.1.1. Reusable
    • 11.1.2. Single Use
  • 11.2. Fiber-Optic Ureteroscopes
    • 11.2.1. Reusable
    • 11.2.2. Single Use

12. Ureteroscopy Devices Market, by Accessories

  • 12.1. Laser Fibers
    • 12.1.1. Holmium Laser Fibers
    • 12.1.2. Thulium Laser Fibers
  • 12.2. Stone Baskets
    • 12.2.1. Standard Baskets
    • 12.2.2. Tipless Baskets

13. Ureteroscopy Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Ureteroscopy Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Ureteroscopy Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Olympus Corporation
    • 16.3.2. KARL STORZ SE & Co. KG
    • 16.3.3. Boston Scientific Corporation
    • 16.3.4. Cook Medical LLC
    • 16.3.5. Stryker Corporation
    • 16.3.6. Richard Wolf GmbH
    • 16.3.7. Ambu A/S
    • 16.3.8. Fujifilm Holdings Corporation
    • 16.3.9. Teleflex Incorporated
    • 16.3.10. Coloplast A/S

LIST OF FIGURES

  • FIGURE 1. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. URETEROSCOPY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. URETEROSCOPY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. URETEROSCOPY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL FLEXIBLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC FLEXIBLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SEMI-RIGID URETEROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY INSPECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY VISUALIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BASKET EXTRACTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY BIOPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER ABLATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FREESTANDING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITAL AFFILIATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY SINGLE USE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY HOLMIUM LASER FIBERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY THULIUM LASER FIBERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY STANDARD BASKETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY TIPLESS BASKETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL URETEROSCOPY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 275. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 276. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 277. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 278. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 279. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 280. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 281. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 282. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIGITAL URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FIBER-OPTIC URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY ACCESSORIES, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY LASER FIBERS, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE BASKETS, 2025-2032 (USD MILLION)
  • TABLE 299. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 300. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 301. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 302. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 303. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2018-2024 (USD MILLION)
  • TABLE 304. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY FLEXIBLE URETEROSCOPES, 2025-2032 (USD MILLION)
  • TABLE 305. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 307. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2018-2024 (USD MILLION)
  • TABLE 308. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY DIAGNOSTIC, 2025-2032 (USD MILLION)
  • TABLE 309. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2018-2024 (USD MILLION)
  • TABLE 310. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY THERAPEUTIC, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY STONE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY TUMOR MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA URETEROSCOPY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2032